Spectral AI, Inc. develops AI-driven medical diagnostics for wound care through its DeepView® System, a predictive diagnostic device and software platform for burn wound assessment. Company news centers on DeepView demonstrations at burn-care meetings, BARDA-supported development, FDA De Novo 510(k) submission activity, and preparation for U.S. commercialization.
Updates also cover quarterly and annual financial results, research and development revenue tied to government-supported work, cash resources, and executive or board leadership changes.
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.36%
Tags
-
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.87%
Tags
-
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.50%
Tags
News
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
-
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.38%
Tags
-
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.32%
Tags
FAQ
What is the current stock price of Spectral AI Warrants (MDAIW)?
Spectral AI Warrants (MDAIW) last closed at $0.4700.